Statistics in Medicine — Reporting of Subgroup Analyses in Clinical Trials
Top Cited Papers
- 22 November 2007
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 357 (21) , 2189-2194
- https://doi.org/10.1056/nejmsr077003
Abstract
Medical research relies on clinical trials to assess therapeutic benefits. Because of the effort and cost involved in these studies, investigators frequently use analyses of subgroups of study participants to extract as much information as possible. Such analyses, which assess the heterogeneity of treatment effects in subgroups of patients, may provide useful information for the care of patients and for future research. However, subgroup analyses also introduce analytic challenges and can lead to overstated and misleading results.1-7 This report outlines the challenges associated with conducting and reporting subgroup analyses, and it sets forth guidelines for their use in the Journal. Although this report focuses on the reporting of clinical trials, many of the issues discussed also apply to observational studies.Keywords
This publication has 18 references indexed in Scilit:
- The Challenge of Subgroup Analyses — Reporting without DistortingNew England Journal of Medicine, 2006
- Calcium plus Vitamin D Supplementation and the Risk of FracturesNew England Journal of Medicine, 2006
- Subgroup analyses in therapeutic cardiovascular clinical trials: Are most of them misleading?American Heart Journal, 2006
- Subgroup analysis in randomised controlled trials: importance, indications, and interpretationThe Lancet, 2005
- Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practiceand problemsStatistics in Medicine, 2002
- Subgroups, treatment effects, and baseline risks: Some lessons from major cardiovascular trialsAmerican Heart Journal, 2000
- Subgroup analysis and other (mis)uses of baseline data in clinical trialsThe Lancet, 2000
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trialsPublished by American Medical Association (AMA) ,1991
- Patient subsets and variation in therapeutic efficacy.British Journal of Clinical Pharmacology, 1982